Endocrine oncology

TSH Cutoffs and Recurrence Risk in Differentiated Thyroid Carcinomas: A Systematic Review and Meta-Analysis

J Clin Endocrinol MetabPublished Systematic review and meta-analysis

Authors' conclusion

The degree of TSH suppression did not affect the overall risk of DTC recurrence. However, TSH suppression may be beneficial in reducing the recurrence risk in high-risk patients with distant metastases.

Study context

Population
Patients with differentiated thyroid cancer (DTC), stratified by American Thyroid Association (ATA) risk of recurrence; studies reporting recurrence rate of DTC by TSH cutoffs (Ovid-Medline, EMBASE, Cochrane through March 2024)2 RCTs and 7 observational studies
Participants
5,320 patients
Comparison
Recurrence risk by TSH cutoffs
Outcome
Risk of DTC recurrence according to TSH cutoffs (0.1, 0.5 and 2.0 mIU/L)
Methodological detailsincludes randomised controlled trials and observational studies, subgroup analysis by ATA risk of recurrence, leave-one-out meta-analysis
  • Includes randomised controlled trials and observational studies
  • Subgroup analysis by ATA risk of recurrence
  • Leave-one-out meta-analysis

Pooled result

As reported in the abstract

Pooled recurrence risk by TSH cutoff

Overall recurrence rate

18%

Further pooled results

Subgroups by ATA risk of recurrence (low- and high-risk DTC)

Pooled hazard ratios (HRs) did not differ according to TSH levels
  • Subgroup analysis

Recurrence risk, serum TSH ≥0.1 mIU/L

HR
2.27 (95% CI 1.29-3.99)
  • Leave-one-out meta-analysis after removing the study that significantly influenced the analysis

Recurrence risk, TSH ≥2.0 mIU/L

HR
1.36 (95% CI 1.001-1.84)
  • Leave-one-out meta-analysis after removing the study that significantly influenced the analysis

Recurrence risk in patients with distant metastases, TSH ≥0.1 mIU/L

HR
3.3 (95% CI 1.53-7.10)

Original publication

TSH Cutoffs and Recurrence Risk in Differentiated Thyroid Carcinomas: A Systematic Review and Meta-Analysis. J Clin Endocrinol Metab. Published 14 August 2025. doi:10.1210/clinem/dgaf463

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.